Postdoctoral Training Program in Pulmonary and Critical Care Translational Research
肺部和重症监护转化研究博士后培训项目
基本信息
- 批准号:10700843
- 负责人:
- 金额:$ 4.22万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-07-01 至 2024-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Project Summary/Abstract
We enthusiastically submit this revised application for our T32 training program here at the University of Illinois at
Chicago (UIC) entitled Postdoctoral Training Program in Pulmonary and Critical Care Translational
Research. The primary goal of our program is the career development of the next generation of scientific leaders
in the fields of pulmonary and critical care medicine along three integrated thematic pathways that provide
comprehensive training in 1) Lung Injury and Inflammation, 2) Precision Medicine and Computational Approaches,
and 3) Comparative Effectiveness and Health Inequality. This innovative new program builds upon our experience
and success achieved over a recent 10 year period with a prior postdoctoral T32 based here in our Division of
Pulmonary, Critical Care, Sleep, and Allergy. This prior program had an outstanding trajectory of success, with
our recent T32 trainees earning 3 new K08s, 1 K23, and 1 R01 in the past two years alone. Moreover, 13 out
of the last 18 T32 fellows in our prior program continue to pursue scientifically-oriented careers. With this new
program, we build upon this impressive history of success and have substantially advanced and expanded our
training environment through the recruitment of multiple new faculty. The addition of their various areas of scientific
expertise brings new state-of-the-art dimensions to our training environment. Our underlying premise and
unifying hypothesis is that an integrated program focused on cutting-edge research approaches will
inspire a new generation of successful scientific leaders in lung diseases. With frequent input and feedback
from faculty, trainees, and internal and external advisors, we continually enhance and improve our training program
to optimize the career development and scientific success of our trainees. Major programmatic enhancements in
this new program include the following:
Faculty expansion and development have added training opportunities in multiple new fields—lung
microbiome, sarcoidosis, lung cancer, precision medicine, computational modeling, healthcare design,
population health science
Transition to a multi-PI leadership structure to optimize program oversight and growth
Detailed description of current training timeline and trainee milestones
Formation of a Minority Advisory Committee
Incorporation of former T32 trainees and junior faculty into the program as “near peer” advisors
Required training in scientific rigor and reproducibility for T32 trainees
Expanded annual training in mentorship that is required for faculty
Incorporation of a PhD Training Committee to enhance recruitment and training of PhD candidates
“360 degree evaluation” with emphasis on current and former trainee program reviews at annual retreat
Candidates will be accepted for 2-3 years of research training based on exceptional personal qualifications.
项目总结/摘要
我们热情地提交我们的T32培训计划在伊利诺伊大学在这里修改后的申请,
芝加哥(UIC)题为博士后培训计划在肺部和重症监护翻译
Research.我们计划的主要目标是下一代科学领导者的职业发展
在肺部和重症监护医学领域,沿着三个综合主题途径,提供
在1)肺损伤和炎症,2)精准医学和计算方法,
(3)比较有效性和健康不平等。这一创新的新方案建立在我们的经验
并取得了成功,在最近10年的时间内,与以前的博士后T32在这里设在我们的司
肺、重症监护、睡眠和过敏。这个先前的计划有一个杰出的成功轨迹,
我们最近的T32学员仅在过去两年就获得了3个新的K 08,1个K23和1个R 01。此外,13个
在我们之前的项目中,最后18名T32研究员中的30%继续追求科学导向的职业生涯。有了这个新
计划,我们建立在这一令人印象深刻的成功历史,并大大推进和扩大了我们的
通过招聘多名新教师来改善培训环境。他们的各种科学领域的增加
专业知识为我们的培训环境带来了新的最先进的维度。我们的基本前提和
统一的假设是,一个集中在尖端研究方法的综合计划将
激励新一代成功的肺部疾病科学领导者。通过频繁的输入和反馈
从教师,学员,内部和外部顾问,我们不断加强和改善我们的培训计划,
优化学员的职业发展和科学成功。主要方案改进
这一新方案包括以下内容:
师资队伍的扩大和发展增加了多个新领域的培训机会-龙
微生物组,结节病,肺癌,精准医学,计算建模,医疗设计,
人口健康学
过渡到多PI领导结构,以优化计划监督和增长
详细描述当前培训时间轴和学员里程碑
组建少数群体咨询委员会
将前T32学员和初级教师作为“近同行”顾问纳入该计划
* T32受训人员需要接受科学严谨性和可重复性方面的培训
* 扩大教师所需的导师年度培训
设立博士培训委员会,以加强博士候选人的招聘和培训
在年度务虚会上进行“360度评估”,重点是对现任和前任培训生计划的审查
候选人将被接受2-3年的研究培训基于特殊的个人资格。
项目成果
期刊论文数量(6)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Preliminary Observations of Veterans Without HIV Who Have Mycobacterium avium Complex Pulmonary Disease.
对未感染艾滋病毒但患有鸟分枝杆菌复杂肺部疾病的退伍军人的初步观察。
- DOI:10.12788/fp.0230
- 发表时间:2022
- 期刊:
- 影响因子:0
- 作者:Vagts,ChristenL;Rubinstein,Israel
- 通讯作者:Rubinstein,Israel
Impact of the Coronavirus Disease 2019 Pandemic on Physical and Mental Health of Patients With COPD: Results From a Longitudinal Cohort Study Conducted in the United States (2020-2021).
2019 年冠状病毒病大流行对慢性阻塞性肺病患者身心健康的影响:在美国进行的一项纵向队列研究的结果(2020-2021 年)。
- DOI:10.15326/jcopdf.2022.0287
- 发表时间:2022
- 期刊:
- 影响因子:0
- 作者:Zhang,WilliamZ;LaBedz,StephanieL;Holbrook,JanetT;Gangemi,Andrew;Baalachandran,Ramasubramanian;Eakin,MichelleN;Wise,RobertA;Sumino,Kaharu;AmericanLungAssociationAirwaysClinicalResearchCenters
- 通讯作者:AmericanLungAssociationAirwaysClinicalResearchCenters
Infection prevention in sarcoidosis: proposal for vaccination and prophylactic therapy.
- DOI:10.36141/svdld.v37i2.9599
- 发表时间:2020
- 期刊:
- 影响因子:0
- 作者:Syed H;Ascoli C;Linssen CF;Vagts C;Iden T;Syed A;Kron J;Polly K;Perkins D;Finn PW;Novak R;Drent M;Baughman R;Sweiss NJ
- 通讯作者:Sweiss NJ
Pragmatic Clinical Trial to Improve Patient Experience Among Adults During Transitions from Hospital to Home: the PArTNER study.
改善成人从医院到家庭过渡期间患者体验的实用临床试验:PArTNER 研究。
- DOI:10.1007/s11606-022-07461-0
- 发表时间:2022
- 期刊:
- 影响因子:5.7
- 作者:LaBedz,StephanieL;Prieto-Centurion,Valentin;Mutso,Amelia;Basu,Sanjib;Bracken,NinaE;Calhoun,ElizabethA;DiDomenico,RobertJ;Joo,Min;Pickard,ASimon;Pittendrigh,Barry;Williams,MarkV;Illendula,Sai;Krishnan,JerryA
- 通讯作者:Krishnan,JerryA
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
STEVEN M DUDEK其他文献
STEVEN M DUDEK的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('STEVEN M DUDEK', 18)}}的其他基金
Pathobiology of MRSA-induced Endothelial Permeability and Acute Lung Injury
MRSA 诱导的内皮通透性和急性肺损伤的病理学
- 批准号:
10608606 - 财政年份:2022
- 资助金额:
$ 4.22万 - 项目类别:
Fostering Academic Physician-Investigators Treating High Risk Populations
培养治疗高危人群的学术医师研究人员
- 批准号:
10647841 - 财政年份:2021
- 资助金额:
$ 4.22万 - 项目类别:
Fostering Academic Physician-Investigators Treating High Risk Populations
培养治疗高危人群的学术医师研究人员
- 批准号:
10459247 - 财政年份:2021
- 资助金额:
$ 4.22万 - 项目类别:
Postdoctoral Training Program in Pulmonary and Critical Care Translational Research
肺部和重症监护转化研究博士后培训项目
- 批准号:
10472480 - 财政年份:2019
- 资助金额:
$ 4.22万 - 项目类别:
Postdoctoral Training Program in Pulmonary and Critical Care Translational Research
肺部和重症监护转化研究博士后培训项目
- 批准号:
9791769 - 财政年份:2019
- 资助金额:
$ 4.22万 - 项目类别:
Postdoctoral Training Program in Pulmonary and Critical Care Translational Research
肺部和重症监护转化研究博士后培训项目
- 批准号:
10198029 - 财政年份:2019
- 资助金额:
$ 4.22万 - 项目类别:
Crosstalk between S1P Receptor 1/S1P1 and P-Selectin/Selp in Regulation of Inflammatory Vascular Permeability
S1P 受体 1/S1P1 和 P-选择素/Selp 之间的串扰调节炎症血管通透性
- 批准号:
10871784 - 财政年份:2016
- 资助金额:
$ 4.22万 - 项目类别:
相似国自然基金
胚胎脑发育的分子机理:lgl2(late gestation lung 2)蛋白质的生物学功能的研究
- 批准号:30470854
- 批准年份:2004
- 资助金额:18.0 万元
- 项目类别:面上项目
相似海外基金
Interplay of the extracellular matrix and immune cells in lung pathology: key role for chitinase-like proteins
肺病理学中细胞外基质和免疫细胞的相互作用:几丁质酶样蛋白的关键作用
- 批准号:
MR/Y003683/1 - 财政年份:2024
- 资助金额:
$ 4.22万 - 项目类别:
Research Grant
Phase Ib/II study of safety and efficacy of EZH2 inhibitor, tazemetostat, and PD-1 blockade for treatment of advanced non-small cell lung cancer
EZH2 抑制剂、他泽美司他和 PD-1 阻断治疗晚期非小细胞肺癌的安全性和有效性的 Ib/II 期研究
- 批准号:
10481965 - 财政年份:2024
- 资助金额:
$ 4.22万 - 项目类别:
Uncovering the epigenetic face of lung fibrosis for discovery of novel biomarkers and treatments.
揭示肺纤维化的表观遗传面,以发现新的生物标志物和治疗方法。
- 批准号:
MR/X032914/1 - 财政年份:2024
- 资助金额:
$ 4.22万 - 项目类别:
Fellowship
Persistent micro- and nanoplastics as triggers for interstitial lung disease
持久性微塑料和纳米塑料是间质性肺病的诱因
- 批准号:
MR/Y012682/1 - 财政年份:2024
- 资助金额:
$ 4.22万 - 项目类别:
Research Grant
気道上皮バリアに着目した肺NTM症Lung-on-a-chipモデルの構築と応用
关注气道上皮屏障的肺NTM疾病芯片肺模型的构建与应用
- 批准号:
24K19096 - 财政年份:2024
- 资助金额:
$ 4.22万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
- 批准号:
10752129 - 财政年份:2024
- 资助金额:
$ 4.22万 - 项目类别:
Interaction between immunity and airway remodelling in lung disease.
肺部疾病中免疫与气道重塑之间的相互作用。
- 批准号:
502582 - 财政年份:2024
- 资助金额:
$ 4.22万 - 项目类别:
Bioactive fragments of the extracellular matrix orchestrate lung epithelial cell repair.
细胞外基质的生物活性片段协调肺上皮细胞修复。
- 批准号:
BB/Y004183/1 - 财政年份:2024
- 资助金额:
$ 4.22万 - 项目类别:
Research Grant
Tractable human distal lung organoid model as a new efficient tool to study mesenchymal-epithelial interactions in COPD
易处理的人远端肺类器官模型作为研究慢性阻塞性肺病间充质-上皮相互作用的新有效工具
- 批准号:
NC/Y500641/1 - 财政年份:2024
- 资助金额:
$ 4.22万 - 项目类别:
Training Grant
Cellular dynamics in chronic lung disease: the neglected B cell axis
慢性肺病的细胞动力学:被忽视的 B 细胞轴
- 批准号:
MR/X03383X/1 - 财政年份:2024
- 资助金额:
$ 4.22万 - 项目类别:
Fellowship